Drug intelligence / Profile preview

guli capsule

Development stage: Phase 4
Lead developer: Guizhou Bailing Group Pharmaceutical
Administration: Oral

Overview

**Guli capsule** is an oral traditional Chinese herbal medicine product manufactured by Guizhou Bailing for musculoskeletal symptoms and osteoporosis. The capsule contains a defined nine-herb formula comprising epimedium, Cibotium rhizome, Clematis root, papaya, achyranthes root, turmeric, psoralea fruit, codonopsis root, and kudzu root. Its labeled traditional-use functions are to strengthen bones and tendons, dispel rheumatism, promote blood circulation, relieve pain, and improve symptoms including low back and leg pain, limb numbness, and osteoporosis. A randomized multicenter Phase 4 study evaluated Guli capsule in knee osteoarthritis. ([ypk.39.net](https://ypk.39.net/1000000643/manual))

Brand names: 百灵鸟
Other names: GuLiJiaoNang骨力胶囊

Beyond the preview

Go deeper on guli capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on guli capsule.

Explore the full profile